Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEland Oil & Gas Regulatory News (ELA)

  • There is currently no data for ELA

Directorate Changes

15 Sep 2014 07:00

RNS Number : 6056R
Eland Oil & Gas PLC
15 September 2014
 



 

15 September 2014

 

Eland Oil & Gas PLC

("Eland" or the "Company")

 

Directorate Changes

 

Eland Oil & Gas PLC (AIM: ELA), an oil & gas development and exploration company operating in West Africa with an initial focus on Nigeria, today announces the resignation of Andrew Bartlett from his position as a Non-Executive Director of the Company. Eland would like to thank Andrew for all his work and contribution to the Company since 2012. We wish him well in his future endeavours.

 

Eland is pleased to announce the appointment of Dr Richard Norris as Non-Executive Director of the Company to replace Andrew Bartlett. Richard joins the Board today and will represent Helios Natural Resources, a significant shareholder in Eland.

 

Dr Richard Norris has over 25 years' oil and gas experience and is currently Upstream Adviser to Helios Investment Partners. In his early career, Richard held the position of Reservoir Engineer at Elf Aquitaine, subsequently Total, covering upstream operations, reserves, new ventures and economic strategy over a ten year period in France and Angola. Later he established the Technical Director role at BNP Paribas in its European oil and gas structured finance group. More recently he was General Operations Manager for Geopetrol and subsequently in 2010-2011 Richard was CEO and President of the TSX listed Candax Energy.

 

Richard holds a PhD in Petroleum Engineering and an MSc in Petroleum Geology from Imperial College London as well as a BSc in Geology.

 

Dr Richard Norris (age 48) directorships in the last five years are as follows:

 

Current

Wannasurf.com Limited

Pandreco Limited

 

Last 5 years

Candax Energy Limited

 

Richard Norris shareholdings in the Company:

Under a success fee arrangement with Helios, Richard Norris is a Limited Partner in HNR Co-Investment Partners LLP ("HNR Co-Investment"), with Helios as the General Partner, whereby HNR Co-Investment indirectly holds on Richard Norris's behalf, 79,845 ordinary shares in Eland (representing 0.06% of the current issued share capital of the Company) through its investment in Helios Natural Resources Ltd whose only asset is shares in Eland. Any monetisation of the indirect stake is at the sole discretion of the General Partner.

Helios hold, through Helios Natural Resources Limited, 39,600,000 ordinary shares in the Company, including those held on behalf of Dr Norris as described above, representing 28.03% of the current issued share capital of the Company. Helios Natural Resources also hold an additional 10,000,000 Non-Voting Shares.

 

There is no further information to be disclosed in relation to schedule 2 paragraph (g) of the AIM rules.

 

 

For further information:

Eland Oil & Gas PLC

+44 (0) 207 016 3180

George Maxwell, CEO

 

Louis Castro, CFO

 

Edward Cozens, IR

 

 

 

Canaccord Genuity Limited

+44 (0) 207 523 8000

Henry Fitzgerald-O'Connor

 

Peter Stewart

 

 

FirstEnergy Capital LLP

+44 (0) 207 448 0200

Majid Shafiq

 

Khalid Ahmed

 

 

Citigate Dewe Rogerson

+44 (0) 207 638 9571

Martin Jackson

Shabnam Bashir

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGGUCGBUPCGRC
Date   Source Headline
15th Nov 20062:50 pmRNSAnnual Report
25th Oct 20062:18 pmRNSBlocklisting Interim Review
25th Oct 20067:30 amBUSElan Reports Third Quarter 2006 Financial Results
24th Oct 20061:00 pmBUSTYSABRI(R) Maintained Remission in Patients with Moderate-to-Severe Crohn's Disease Treated for Longer Than Two Years According to Data Presented This Week
18th Oct 20068:42 amRNSHolding in Company
10th Oct 20067:00 amBUSNotice of Results
6th Oct 20062:07 pmBUSNew Pharmacoeconomic Data on TYSABRI(R) Demonstrate Significant Reduction in Steroid Use and Hospitalizations in Patients with Multiple Sclerosis
4th Oct 20061:00 pmBUSHealth Canada Grants Approval of TYSABRI(TM) (natalizumab) for the Treatment of Multiple Sclerosis Following Priority Review
29th Sep 20062:00 pmBUSNew Data Presented at ECTRIMS Congress Show TYSABRI(R) Has Sustained Effect on Relapse Rate in Multiple Sclerosis Patients Treated for up to Three Years
11th Sep 200611:57 amRNSFinancial Statements
9th Aug 20068:58 amRNSHolding in Company
2nd Aug 20065:26 pmRNSDirector/PDMR Shareholding
2nd Aug 200612:12 pmRNSHolding in Company
29th Jun 200612:32 pmRNSHolding in Company
21st Jun 200610:01 amRNSHolding in Company
15th Jun 20068:20 amRNSHolding in Company
7th Jun 20068:02 amRNSFurther re Appointment
1st Jun 200611:58 amRNSHolding in Company
25th May 20063:31 pmRNSHolding in Companies
25th May 200612:37 pmRNSHolding in Company
19th May 20065:51 pmRNSDirectors/PDMR Shareholding
19th May 200610:56 amRNSHolding in Company
17th May 200612:16 pmRNSHolding in Company
12th May 20061:45 pmRNSDirector/PDMR Shareholding
24th Apr 200611:36 amRNSHolding in Company
20th Apr 20064:44 pmRNSDocument Availability
19th Apr 20063:30 pmRNSHolding in Company
13th Apr 200612:51 pmRNSHolding in Company
13th Apr 200612:04 pmRNSAnnual Information Update
10th Apr 200612:42 pmRNSBrochure of Particulars
3rd Apr 20063:39 pmRNSBrochure of Particulars
13th Mar 200611:47 amRNSHoldings in Company
10th Mar 20063:24 pmRNSDirector/PDMR Shareholding
9th Mar 20067:30 amRNSRestoration of Listing
9th Mar 20067:01 amRNSOL Notice - Restoration
7th Mar 20061:00 pmRNSSuspension - Elan Corp Plc
7th Mar 20061:00 pmRNSOL Notice - Suspension
15th Feb 200610:15 amRNSBrochure of Particulars
10th Feb 20064:55 pmRNSDirector/PDMR Shareholding
9th Feb 20065:32 pmRNSDirector/PDMR Shareholding
9th Feb 20063:54 pmRNSHolding in Company
8th Feb 200610:56 amRNSDirector/PDMR Shareholding
3rd Feb 20069:58 amRNSDirector/PDMR Shareholding
25th Jan 200611:19 amRNSHolding in Company
9th Dec 20054:02 pmRNSDirector/PDMR Shareholding
17th Nov 20052:31 pmRNSRE:Director/PDMR Shareholding
1st Nov 20055:32 pmRNSDirector/PDMR Shareholding
22nd Sep 20059:43 amRNSRe: Brochure of Particulars
23rd Aug 20055:12 pmRNSDirector/PDMR Shareholding
21st Jun 200511:32 amRNSBrochure of Particulars

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.